Gangwal Healthcare to set up unit for manufacturing nutraceuticals

Published - January 29, 2022 09:58 pm IST

Gangwal Healthcare Pvt. Ltd., which was spun off as a separate company from Gangwal Chemicals Pvt. Ltd. in this financial year, has announced plans to set up a large facility for manufacturing of nutraceuticals considering the growing demand in this segment.

“We have finalised plans to set up a large unit for manufacturing of proteins and supplements in the nutraceuticals and wellness segment. We have already acquired 3.5 acres land for this plant in Tarapur, Maharashtra,” Anil Jain, MD, Gangwal Group of companies said. He said the plant will have a total investment of ₹60 crore out of which about ₹35 crore will be mobilised as bank loan. To begin with this plant will spread over 100,000 sq ft area and will be operational in the January-March quarter of 2024.

“This will be our major investment in the health and wellness segment. According to a McKinsey report, the wellness segment is estimated $1.3 trillion growing at 5-10% a year. We are expecting major business from this stream because this concept is under explored now,” Mr. Jain said.

The company already has four manufacturing units in Tarapur for its pharmaceutical and personal care product lines. It also runs a laboratory business providing testing facilities for clients. Recently, the promoters sold majority stake in Gangwal Chemicals to Dutch company Barentz International BV for an unspecified amount.

After divestment of the trading business to Barentz, the promoters will now focus to grow the manufacturing business under Gangwal Healthcare.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.